InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Aronson Martha Goldberg, Director. Officer active across 2 companies, notably Cardiovascular Systems Inc. Cumulatively, 7 disclosures have been recorded. Total volume traded: €166k. The latest transaction was filed on 1 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
0812 shares0
Common Stock
SEC:0001127602-22-016531:0·
€40,2222,500 shares@ €16.088824.2% of flow
Common Stock
SEC:0001437749-22-002892:0·
Ideal exit: 4 Nov 2022 (T+270)
€40,2222,500 shares@ €16.088848.5% of flow
Common Stock
SEC:0001437749-22-002892·
Ideal exit: 4 Nov 2022 (T+270)
01,521 shares0
Common Stock
SEC:0001127602-21-018892·
01,521 shares0
Common Stock
SEC:0001127602-21-018892:0·
€42,7361,500 shares@ €28.490451.5% of flow
Common Stock
SEC:0000914190-21-000144·
Ideal exit: 4 Feb 2022 (T+270)
€42,7361,500 shares@ €28.490425.8% of flow
Common Stock
SEC:0000914190-21-000144:0·
Ideal exit: 4 Feb 2022 (T+270)
7 of 7 declarations
About Aronson Martha Goldberg
Martha Goldberg Aronson is a Director at Cardiovascular Systems Inc and CONMED Corp. She provides her expertise to the board, contributing to the strategy and governance of the companies. Her experience is valuable in guiding decisions and ensuring sustainable growth.
